Table 3.
Double-blind, randomized, placebo-controlled trials of NSAIDs in patients with MCI.
Drug | Treatment duration | Dose (mg/day) | No. patients | Main outcome | Reference |
---|---|---|---|---|---|
Rofecoxib | 4 years | 25 | 1,457 | Detrimental effects | Thal et al. (2005) |
Triflusal | 13 months | 900 | 257 | Neutral/beneficial effects | Gómez-Isla et al. (2008) |
Celecoxib | 18 months | 200–400 | 88* | Beneficial effects | Small et al. (2008) |
*Subjects with age-associated memory decline.